Answers are grounded in this paper and cite their sources.
SCS efficacy varies, with explantation rates reaching up to 38%, often due to inadequate pain relief. Most explantations occur within the first year, despite SCS being a safe and effective treatment. High implantation costs ($35,000 to $70,000) and revision costs ($15,000 to $25,000) raise concerns among payors. The hardware-driven model limits waveform flexibility, highlighting the need for innovation.
No takes yet. Share an insight, caveat, or question.
Wahezi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: